The Relationship Between Study Characteristics and the Prevalence of Medication-related Hospitalizations: a Literature Review and Novel Analysis

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2010 Feb 18

PMID 20158287

Citations 47

Authors

Anne J Leendertse

Djurre Visser

Antoine C G Egberts

Patricia M L A Van den Bemt

Affiliations

Soon will be listed here.

Abstract

Background: Studies on medication-related hospitalizations differ in study setting, studied population, outcome, and method of data collection. Thus, extrapolations based on a meta-analysis of unselected studies may be biased.

Objective: To explore the influence of study characteristics on the prevalence of medication-related hospitalizations.

Methods: After a structured literature search, the retrieved studies were categorized based on the following aspects: (i) study setting (e.g. all hospital admissions vs only acute hospital admissions); (ii) study population (e.g. an entire hospital, study ward(s), selected population and/or age group); (iii) outcome of medication-related problem (e.g. adverse drug reaction [ADR] vs adverse drug event [ADE]); (iv) method of data collection (e.g. medical chart review, spontaneous reporting or database research); and (v) continent in which the study took place (only for studies looking at all acute admissions). We then examined the relationship between these factors and reported prevalence of medication-related hospital admissions.

Results: Ninety-five studies were analysed, with a range of reported prevalence of medication-related hospitalizations from 0.1% to 54%. Higher prevalences were found in the studies examining all hospital admissions than in the studies examining only acute hospital admissions. In addition, higher prevalences were found in the elderly population than in children. As would be expected, higher prevalences were also found in studies examining ADEs than in studies examining only ADRs. With respect to the method of data collection, medical chart screening resulted in higher prevalences of medication-related hospitalizations than database methods or spontaneous reporting. Combined studies in Europe show lower prevalences of medication-related hospital admissions than in other continents included in the study.

Discussion: The reported prevalence of medication-related hospital admissions varies as a function of the setting (all admissions or only acute admissions), studied population (entire hospital, specific wards, selected population and age group), outcome (ADR/ADE), the method of data collection and the continent in which the study is performed.

Conclusion: Extrapolation using national hospital admission data and the prevalence identified by pooling international studies should be carried out with great caution.

Citing Articles

Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate.

Beeler P, Stammschulte T, Dressel H Drug Saf. 2023; 46(8):753-763.

PMID: 37335465 PMC: 10344833. DOI: 10.1007/s40264-023-01319-y.

Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis.

Haerdtlein A, Debold E, Rottenkolber M, Boehmer A, Pudritz Y, Shahid F J Clin Med. 2023; 12(4).

PMID: 36835854 PMC: 9963366. DOI: 10.3390/jcm12041320.

Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database.

Choi E, Kim S, Suh H Front Pharmacol. 2022; 13:1047387.

PMID: 36532737 PMC: 9751698. DOI: 10.3389/fphar.2022.1047387.

Evaluation of Factors Associated with Adverse Drug Events in South Korea Using a Population-Based Database.

Choi E, Kim S, Suh H J Clin Med. 2022; 11(21).

PMID: 36362475 PMC: 9657773. DOI: 10.3390/jcm11216248.

Additional value of a triggerlist as selection criterion in identifying patients at high risk of medication-related hospital admission: a retrospective cohort study.

Linkens A, Janssen M, van Nie N, Peeters L, Winkens B, Milosevic V Int J Clin Pharm. 2022; 44(5):1205-1210.

PMID: 36115001 DOI: 10.1007/s11096-022-01447-y.

References

Zargarzadeh A, Emami M, Hosseini F . Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol. 2007; 34(5-6):494-8. DOI: 10.1111/j.1440-1681.2007.04600.x. View

Mckenzie M, Stewart R, WEISS C, Cluff L . A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm. 1973; 30(10):898-903. View

Mannesse C, Derkx F, de Ridder M, Man in t Veld A, van der Cammen T . Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000; 29(1):35-9. DOI: 10.1093/ageing/29.1.35. View

Edwards I, Aronson J . Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000; 356(9237):1255-9. DOI: 10.1016/S0140-6736(00)02799-9. View

Moore N, Lecointre D, Noblet C, Mabille M . Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol. 1998; 45(3):301-8. PMC: 1873369. DOI: 10.1046/j.1365-2125.1998.00667.x. View

Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P . Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999; 54(12):959-63. DOI: 10.1007/s002280050582. View

Pouyanne P, Haramburu F, IMBS J, Begaud B . Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000; 320(7241):1036. PMC: 27343. DOI: 10.1136/bmj.320.7241.1036. View

Beijer H, de Blaey C . Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002; 24(2):46-54. DOI: 10.1023/a:1015570104121. View

Grymonpre R, Mitenko P, Sitar D, Aoki F, Montgomery P . Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988; 36(12):1092-8. DOI: 10.1111/j.1532-5415.1988.tb04395.x. View

10.

Leendertse A, Egberts A, Stoker L, Van den Bemt P . Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008; 168(17):1890-6. DOI: 10.1001/archinternmed.2008.3. View

11.

Malhotra S, Karan R, Pandhi P, Jain S . Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J. 2001; 77(913):703-7. PMC: 1742171. DOI: 10.1136/pmj.77.913.703. View

12.

Pearson T, Pittman D, Longley J, Grapes Z, Vigliotti D, Mullis S . Factors associated with preventable adverse drug reactions. Am J Hosp Pharm. 1994; 51(18):2268-72. View

13.

McKenney J, Harrison W . Drug-related hospital admissions. Am J Hosp Pharm. 1976; 33(8):792-5. View

14.

Howard R, Avery A, Howard P, Partridge M . Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003; 12(4):280-5. PMC: 1743731. DOI: 10.1136/qhc.12.4.280. View

15.

Peyriere H, Cassan S, Floutard E, Riviere S, Blayac J, Hillaire-Buys D . Adverse drug events associated with hospital admission. Ann Pharmacother. 2002; 37(1):5-11. DOI: 10.1345/aph.1C126. View

16.

Miller R . Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974; 134(2):219-23. View

17.

Tranulis C, Skalli L, Lalonde P, Nicole L, Stip E . Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature. Drug Saf. 2007; 31(1):7-20. DOI: 10.2165/00002018-200831010-00002. View

18.

SIDEL V, Koch-Weser J, Barnett G, Eaton A . Drug utilization and adverse reactions in a general hospital. Hospitals. 1967; 41(12):80-8. View

19.

Lin S, Lin M . A survey on drug-related hospitalization in a community teaching hospital. Int J Clin Pharmacol Ther Toxicol. 1993; 31(2):66-9. View

20.

Ramsay L, Freestone S, Silas J . Drug-related acute medical admissions. Hum Toxicol. 1982; 1(4):379-86. DOI: 10.1177/096032718200100403. View